Let’s start up with the current stock price of Context Therapeutics Inc. (CNTX), which is $2.23 to be very precise. The Stock rose vividly during the last session to $2.506 after opening rate of $2.50 while the lowest price it went was recorded $2.365 before closing at $2.39.Recently in News on January 5, 2022, Context Therapeutics® Strengthens Research & Development Team. Company names Christopher Beck as SVP, Operations and Mark Fletcher, Ph.D., as VP, R&D. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Context Therapeutics Inc. shares are logging -79.50% during the 52-week period from high price, and -3.12% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.30 and $10.87.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 618515 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Context Therapeutics Inc. (CNTX) recorded performance in the market was -10.15%. At the time of this writing, the total market value of the company is set at 26.46M, as it employees total of 2 workers.
Context Therapeutics Inc. (CNTX) in the eye of market guru’s
During the last month, 0 analysts gave the Context Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Context Therapeutics Inc. (CNTX): Stocks Technical analysis and Trends
Raw Stochastic average of Context Therapeutics Inc. in the period of last 50 days is set at 0.23%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.55%. In the last 20 days, the company’s Stochastic %K was 9.14% and its Stochastic %D was recorded 11.50%.
If we look into the earlier routines of Context Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -10.15%. The shares increased approximately by -6.27% in the 7-day charts and went up by -35.23% in the period of the last 30 days.